ctrl K

AI Score

Unlock

Voyager Therapeutics Inc. (VYGR)

AI Score

Unlock

3.37

-0.01 (-0.30%)

At close: Apr 01, 2025, 3:59 PM

3.29

-2.46%

After-hours: Apr 01, 2025, 07:56 PM EDT

Voyager Therapeutics Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	80M	250.01M	40.91M	37.41M	171.13M
Cost of Revenue	n/a	4.44M	6.19M	73.79M	108.75M
Gross Profit	80M	245.57M	34.72M	-36.37M	62.38M
Operating Income	-83.29M	122.01M	-50.84M	-73.62M	27.38M
Interest Income	18.33M	11.72M	1.79M	390K	1.66M
Pretax Income	-64.34M	133.74M	-46.39M	-71.2M	36.74M
Net Income	-65M	132.33M	-46.41M	-66.03M	36.74M
Selling & General & Admin	35.92M	35.82M	30.98M	37.25M	34.99M
Research & Development	127.37M	92.17M	60.76M	73.79M	108.75M
Other Expenses	n/a	n/a	4.45M	2.42M	7.7M
Operating Expenses	163.29M	127.99M	91.74M	111.03M	143.74M
Interest Expense	n/a	n/a	1.79M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	163.29M	127.99M	91.74M	111.03M	143.74M
Income Tax	665K	1.41M	16K	-5.17M	-1.66M
Shares Outstanding (Basic)	57.67M	43.02M	38.36M	37.67M	37.13M
Shares Outstanding (Diluted)	57.67M	44.57M	38.36M	37.67M	37.35M
EPS (Basic)	-1.13	3.08	-1.21	-1.75	0.99
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-83.29M	126.45M	-44.65M	-68.45M	31.2M
Depreciation & Amortization	n/a	4.44M	6.19M	5.17M	3.82M